PAPhilip M. Ashton

Philip M. Ashton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Philip M. Ashton has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model

    by Philip M. Ashton, Leonardos Mageiros, James E. Meiring, Angeziwa Chunga-Chirambo, Farhana Khanam, Sabina Dongol, Happy Banda, Abhilasha Karkey, Lorena Preciado-Llanes, Helena Thomaides-Brears, et al.

    Background: Typhoid fever is a systemic infection caused by Salmonella enterica serovar Typhi (S. Typhi) invasion from the gut lumen. Transmission between people occurs through ingestion of contaminated food and water, particularly in settings with poor water and sanitation infrastructure, resulting in over 10 million illnesses annually. As the pathogen invades via the gastrointestinal tract, it is plausible that the gut microbiome may influence the outcome of S. Typhi exposure. There is some evidence that bacteria producing short-chain fatty acids (SCFAs) may create an environment unfavourable to invasive Salmonella, but data from humans is limited. Methods: To investigate the association between the gut microbiome and typhoid fever, we analysed samples collected from three all-age cohorts enrolled in a prospective surveillance study conducted across three settings where typhoid fever is endemic (Dhaka, Bangladesh; Blantyre, Malawi; and Kathmandu, Nepal). Cohorts consisted of acute typhoid fever patients (n = 92), asymptomatic household contacts of typhoid fever patients (representing individuals who were likely exposed to S. Typhi but did not develop the disease, n = 97) and asymptomatic serosurvey participants with high Vi antibody titres (representing individuals who were exposed to S. Typhi and may be carriers, n = 69). The stool microbiomes of each cohort were characterised using shotgun metagenomics, and bacterial diversity, composition and function were compared. Results: We identified 4 bacterial species that were significantly lower in abundance in typhoid fever patients compared with household contacts (i.e. probably exposed), in two of the three participant populations (Bangladesh and Malawi). These bacteria may represent taxa that provide protection against the development of clinical infection upon exposure to S. Typhi and include the inflammation-associated species Prevotella copri clade A and Haemophilus parainfluenzae. Our functional analysis identified 28 specific metabolic gene clusters (MGCs) negatively associated with typhoid fever in Bangladesh and Malawi, including seven MGCs involved in SCFA metabolism. The putative protection provided by microbiome SCFA metabolism was supported by data from a controlled human infection model conducted in a UK population, in which participants who did not develop typhoid fever following ingestion of S. Typhi had a higher abundance of a putative SCFA-metabolising MGC (q-value = 0.22). Conclusions: This study identified the same protective associations between taxonomic and functional microbiota characteristics and non-susceptibility to typhoid fever across multiple human populations. Future research should explore the potential functional role of SCFAs and inflammation-associated bacteria in resistance to S. Typhi and other enteric infections.


  • Open Access

    Enterotoxigenic Escherichia coli in Blantyre, Malawi

    by Philip M. Ashton, Zefaniah Joel Katuah, Arnold Botomani, Belson M. Kutambe, Nigel A. Cunliffe, Astrid von Mentzer, Chisomo Msefula, Khuzwayo C. Jere

    We announce the deposition of the first two enterotoxigenic Escherichia coli (ETEC) genomes from Malawi. They were isolated from the faeces of asymptomatically infected children obtained in 2014. Both genomes encode the porcine variant of the heat-labile toxin and no known ETEC colonization factors.


  • Open Access

    A description of lineage 1 Mycobacterium tuberculosis from papua, Indonesia

    by Hanif A.K. Djunaedy, Clarissa A. Febinia, Raph L. Hamers, Kevin Baird, Iqbal Elyazar, Nguyen Thuy Thuong Thuong, Hidayat Trimarsanto, Safarina G. Malik, Guy Thwaites, Reinout van Crevel, et al.


  • Open Access

    Enterotoxigenic Escherichia coli in Blantyre, Malawi

    by Philip Ashton, Zefaniah Joel Katuah, Arnold Botomani, Belson M. Kutambe, Nigel A. Cunliffe, Astrid von Mentzer, Chisomo Msefula, Khuzwayo C. Jere

    We announce the deposition of the first two enterotoxigenic Escherichia coli (ETEC) genomes from Malawi. They were isolated from the faeces of asymptomatically infected children obtained in 2014. Both genomes encode the porcine variant of the heat labile toxin and no known ETEC colonisation factors.

  • Open Access

    Interplay Between the Gut Microbiome and Typhoid Fever: Insights from Endemic Countries and a Controlled Human Infection Model

    by Philip M. Ashton, Leonardos Mageiros, James E. Meiring, Angeziwa Chunga Chirambo, Farhana Khanam, Happy Banda, Abhilasha Karkey, Sabina Dongol, Lorena Preciado Llanes, Helena Thomaides-Brears, et al.

    Typhoid fever is a systemic infection caused by Salmonella enterica serovar Typhi ( S. Typhi) invasion from the gut lumen. Transmission between people occurs through ingestion of contaminated food and water, particularly in settings with poor water and sanitation infrastructure, resulting in over 10 million illnesses annually. As the pathogen invades via the gastrointestinal tract, it is plausible that the gut microbiome may influence the outcome of S . Typhi exposure. There is some evidence that bacteria producing short-chain fatty acids (SCFAs) may create an environment unfavourable to invasive Salmonella, but data from humans is limited. To investigate the association between gut microbiome and typhoid fever, we analysed samples collected from three all-age cohorts enrolled in a prospective surveillance study conducted across three settings where typhoid fever is endemic (Dhaka, Bangladesh; Blantyre, Malawi; and Kathmandu, Nepal). Cohorts consisted of acute typhoid fever patients (n=92), asymptomatic household contacts of typhoid fever patients (representing individuals who were likely exposed to S . Typhi but did not develop disease, n=97), and asymptomatic serosurvey participants with high Vi antibody titres (representing individuals who were exposed to S . Typhi and may be carriers, n=69). The stool microbiomes of each cohort were characterised using shotgun metagenomics, and bacterial diversity, composition, and function were compared. We identified 4 bacterial species that were significantly lower in abundance in typhoid fever patients compared with household contacts (i.e. probably exposed), in two of the three participant populations (Bangladesh and Malawi). These bacteria may represent taxa that provide protection against development of clinical infection upon exposure to S . Typhi, and include the inflammation-associated species Prevotella copri clade A and Haemophilus parainfluenzae . Our functional analysis identified 28 specific metabolic gene clusters (MGCs) negatively associated with typhoid fever in Bangladesh and Malawi, including seven MGCs involved in SCFA metabolism. The putative protection provided by microbiome SCFA metabolism was supported by data from a controlled human infection model conducted in a UK population, in which participants who did not develop typhoid fever following ingestion of S . Typhi had higher abundance of a putative SCFA-metabolising MGC (q-value = 0.22). This study identified the same protective associations between taxonomic and functional microbiota characteristics and non-susceptibility to typhoid fever across multiple human populations. Future research should explore the potential functional role of SCFAs and inflammation-associated bacteria in resistance to S. Typhi and other enteric infections.


  • Open Access

    Enterotoxigenic Escherichia coli in Blantyre, Malawi

    by Philip Ashton, Zefaniah Joel Katuah, Arnold Botomani, Belson M. Kutambe, Nigel A. Cunliffe, Astrid von Mentzer, Chisomo Msefula, Khuzwayo C. Jere

    We announce the deposition of the first two enterotoxigenic Escherichia coli (ETEC) genomes from Malawi. They were isolated from the faeces of asymptomatically infected children obtained in 2014. Both genomes encode the porcine variant of the heat labile toxin and no known ETEC colonisation factors.

  • Open Access

    A description of Lineage 1 Mycobacterium tuberculosis from Papua, Indonesia

    by Hanif A. K. Djunaedy, Clarissa A. Febinia, Raph L. Hamers, Kevin Baird, Iqbal Elyazar, Nguyen Thuy Thuong Thuong, Hidayat Trimarsanto, Safarina G. Malik, Guy Thwaites, Reinout van Crevel, et al.

    Indonesia has the third highest number of tuberculosis (TB) patients infected with Mycobacterium tuberculosis ( MTB ) Lineage 1 (L1). Most of these MTB L1 cases can be found in Indonesia’s remote easternmost province of Papua, one of Indonesia’s most underdeveloped provinces with a particularly high burden for TB. In this study, we sequenced and described 42 MTB L1 isolates from a well-characterized cohort of patients. We found a genetically diverse MTB L1 population with no association between pathogen genetic relatedness and place of residence or pathogen genetic relatedness and patient ethnicity, which could reflect mixing between different locales and ethnicities or our low sampling fraction. Only a small number showed genetic variants associated with drug resistance (5/42, 11.9%), probably due to a lack of effective treatment programs. The Papuan isolates showed similarities to other Island Southeast Asian Countries due to the high proportion of L1.2.1.2.1 (30/42, 71.4%), especially East Timor and the Philippines. This study fills a research gap of MTB L1 in Indonesian Papua and should serve as a stepping stone for further research in the region.

  • Open Access

    Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study

    by Philip M Ashton, Angeziwa Chunga Chirambo, James E Meiring, Priyanka D Patel, Maurice Mbewe, Niza Silungwe, Kenneth Chizani, Happy Banda, Robert S Heyderman, Zoe A Dyson, et al.


  • Open Access

    The rapid emergence of Salmonella Typhi with decreased ciprofloxacin susceptibility following an increase in ciprofloxacin prescriptions in Blantyre, Malawi

    by Philip M. Ashton, Angeziwa Chunga Chirambo, James E. Meiring, Priyanka D. Patel, Maurice Mbewe, Niza Silungwe, Kenneth Chizani, Happy Banda, Robert S. Heyderman, Zoe A. Dyson, et al.

    Ciprofloxacin is the first-line drug for treating typhoid fever in many high burden countries in Africa, but the emergence of non-susceptibility poses a grave challenge to public health programmes. Through enhanced surveillance as part of vaccine evaluation, we set out to investigate the occurrence and determinants of ciprofloxacin non-susceptibility in Blantyre, Malawi. We performed systematic typhoid fever and antibiotic prescription surveillance in two health centres in Blantyre, Malawi between 01/10/2016 and 31/10/2019, as part of the STRATAA and TyVAC studies. Blood culture isolates from study participants underwent i) pefloxacin screening and ciprofloxacin E-tests to identify ciprofloxcain non-susceptibility and ii) whole genome sequencing (WGS) to identify drug resistance mutations and phylogenetic relationships between non-susceptible and sensitive isolates. We constructed generalised linear regression models to investigate associations between ciprofloxacin prescription rates and S. Typhi isolates with Quinolone Resistance Determining Region (QRDR) mutations. We carried out 11295 blood cultures and microbiologically confirmed 239 cases of typhoid fever, with isolates from 193 participants sequenced (mean age of participants with sequenced genomes 12.8 years, 47% male). Between October 2016 and August 2019 2% (n=4/175) of WGS-confirmed typhoid fever cases were caused by S. Typhi with QRDR mutations, compared with 33% (n=6/18) in September and October 2019. Nine of the ten S. Typhi with QRDR mutations had a decreased ciprofloxacin susceptibility phenotype. Every additional prescription of ciprofloxacin given to study participants in the preceding month was associated with a 4.2% increase in the relative risk of isolating S. Typhi with a QRDR mutation (95% CI, 1.8-7.0%, p=0.0008). Phylogenetic analysis showed that S. Typhi isolates with QRDR mutations in September/October 2019 belonged to two distinct sub-clades encoding two different QRDR mutations, and were closely related (0-6 SNPs) to susceptible S. Typhi endemic to Blantyre. We have shown a close temporal association between empiric antimicrobial usage with an increase of fluoroquinolone non-susceptibility in S . Typhi, with two sub-clades responsible for the increase. Decreasing ciprofloxacin usage by improving typhoid diagnostics could help to limit the emergence of resistance.


  • Open Access

    What is the Source of Infections Causing Invasive NontyphoidalSalmonellaDisease?

    by Esmeda B Chirwa, Helen Dale, Melita A Gordon, Philip M Ashton

    Invasive non-typhoidal Salmonella (iNTS) disease is a clinical condition distinct from Salmonella gastroenteritis. With an overall case fatality rate of 14.5% iNTS remains a major cause of morbidity and mortality, particularly in sub-Saharan Africa. However, the sources of infections that lead to cases of iNTS remain unclear. Broadly, there are two hypotheses as to the source of infections i) transmission from a zoonotic reservoir, similar to other non-typhoidal Salmonelloses or ii) person-to-person transmission. Here we review several recent studies that have asked “what is the source of infections causing invasive non-typhoidal Salmonella disease?”. Two studies reported isolates in the stool of household members of iNTS cases that were very closely related (<3 SNPs) to the iNTS case isolates - this is consistent with the hypothesis of person-to-person transmission, but infection from a common source (e.g. a foodstuff) cannot be excluded. On the other hand, thorough investigations of the domestic environment of iNTS cases and the food pathway found only a single iNTS-associated Enteritidis isolate. Therefore, we recommend that future studies test the hypothesis that iNTS is transmitted between people within the domestic environment. Further studies of food and water pathways are also warranted.